维普期刊资源整合服务平台（V6.5）

163篇 您的检索式：作者名="ESTEVA FJ"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Expression of erbB/HER recptors,hergulin and P38 in primary breast cancer using quantitative immunohistochemistry显示文摘	Esteva FJ Hortobagyi GN Sahin AA	2007	Pathol Oncol Res2007，7，3：	1
2	Cross-talk between the ErbB/I-IER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer 显示文摘	Jin Q Esteva FJ	2008	J Mammary Gland Biol Neoplasia2008，13，4：	1
3	Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer 显示文摘	Jin Q Esteva FJ	2008	J Mammary Gland Biol Neoplasia2008，13，4：	1
4	Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond 显示文摘	Esteva FJ Valero V Pusztai L	2001	Oncologist2001，6，2：	1
5	The current status of docetaxel for metastatic breast cancer显示文摘	Esteva FJ	2002	Oncology (Huntingt)2002，16，66：	1
6	Serum HER-2/neu change predicts clinical outcome to trastuzumab-based therapy显示文摘	Ali SM Esteva FJ Fornier M		0，，18：	1
7	Cross-talk between the ErbB/HER fam ily and the type I insulin-like growth factor recep tor sig naling pathway in breast cancer显示文摘	Jin Q Esteva FJ	2008	J Mammary Gland Bi ol Neop lasia2008，13，4：	1
8	The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells显示文摘	Nahta R Hung MC Esteva FJ	2004	Cancer Res2004，64，7：	1
9	Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer显示文摘	Esteva FJ Seidman AD	2000	Semin Oncol2000，27，611：	1
10	Prognostic significance of phosphorylated p38 mitogen-activated protein kinase and HER-2 expression in lymphnode-positive breast carcinoma显示文摘	Esteva FJ Sahin AA Smith TL	2004	Cancer2004，100，3：	1
11	PTEN,PIK3CA,p-AKT,and p-P70s6k status:association with trastuzumab response and survival in patients with HER-2-positive metastatic breast cancer显示文摘	Esteva FJ Guo H Zhang S		0，，04：	1
12	Survival among women with triple receptor-negative breast cancer and brain metastases显示文摘	Dawood S Broglio K Esteva FJ	2009	Ann Oncol2009，20，：	1
13	Pertuzumab in the treatment of HER -2+ breast cancer显示文摘	Jhaveri K Esteva FJ	2014	Natl compr canc netw2014，12，4：	1
14	Comparison of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in metastatic breast cancer显示文摘	Kaptain S Seidman AD Esteva FJ	2000	Mod Pathol2000，13，1：	1
15	Defining prognosis for women with breast cancer and CNS metastases by HER-2 status 显示文摘	Dawood S Broglio K Esteva FJ	2008	Ann Oncol2008，19，7：	1
16	Growth factor receptors in breast cancer: potential for therapeutic intervention 显示文摘	Natha R Hortobagyi GN Esteva FJ	2003	The Oncologist2003，8，1：	1
17	Emerging agents in the treatment of anthracycline - and taxane - refractory, metastatic breast cancer 显示文摘	Dean - Colomb W Esteva FJ	2008	Semin Oncol2008，35，22：	1
18	Prognostic significance of phosphorylated p38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma显示文摘	Esteva FJ Sahin AA Smith TL	2004	Cancer2004，100，：	1
19	Pathologic changes in breast cancer following neoadjuvant chemotherapy: implications for the assessment of response 显示文摘	Rajah R Esteva FJ Symmans WF	2004	Clin Breast Cancer2004，5，3：	1
20	Prognostic role of a muhigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy显示文摘	Esteva FJ Sahin AA Cristofanilli M	2005	Clin Cancer Rest2005，11，9：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示